< Back to News

For Immediate Release

Contact: Jeanne Thomson
847.836.3330
jthomson@logica3.com

PETNET Pharmaceuticals, Inc. Selects Logica3 to Brand Innovative Technology

Communications firm introduces human element to marketing of sophisticated research instrument


West Dundee, IL—September 9, 2002—Logica3 announced today the completion of a new product launch for PETNET Pharmaceuticals, Inc., the nation's leading provider of radiopharmaceuticals used for positron emission tomography (PET). The new product, microPET®, is a dedicated animal PET scanner for use in biomedical and pharmaceutical research. Logica3 completed the development of the product's brand identity and a series of marketing communication materials.

The product's theme, “A Whole New Perspective,” refers to the way in which the machine provides drug researchers with a new and exciting window into their test subjects and results. Because microPET® provides noninvasive, in vivo imagery, pharmaceutical researchers can now conduct both serial and longitudinal studies on the same animal. In addition, they can follow a single animal over time to monitor the effects of interventions and final outcome.

The key benefit of microPET® is increased efficiencies in the drug development process. microPET® improves the performance and reduces the cost of research on animals. This helps pharmaceutical companies move effective drugs to market earlier. Plus, it enables researchers to more quickly identify ineffective interventions and re-focus their resources on the drugs that will truly make a difference in the treatment of human disease.

“microPET® will revolutionize the drug discovery process,” said Lisa Page, president of Logica3. “Our goal in developing the brand was to communicate the extraordinary technology behind the product in a very human context. I think we succeeded in creating an image of superior technology in the service of improving lives.”

In addition to establishing the brand identity, Logica3 created a suite of supporting communications materials including a product brochure and data sheets.

“Logica3 created a powerful image that reinforces the strength and sophistication of our product,” stated Desmond Longford, product manager for PETNET Pharmaceuticals. “Through their creative efforts, Logica3 has strengthened PETNET's position as a leader in the field of molecular imaging.”

< Back to News